Home
Search
Search Results
Previously Searched
3019 results found
Expand All
Apply All
3019 results found

BIO Urges EPA to Help Boost America’s Rural Economy
Press Release  •  August 20, 2018
On Friday, August 17, the Biotechnology Innovation Organization (BIO) urged the Environmental Protection Agency (EPA) to use its authority under the Renewable Fuel Standard (RFS) program to strengthen America’s biobased economy.
Read More

BIO Comments on RFS Standards for 2019 and Biomass-Based Diesel Volumes for 2020
Letters, Testimony & Comments  •  August 17, 2018
The Biotechnology Innovation Organization (BIO) is pleased to provide comment on the U.S. Environmental Protection Agency’s (EPA’s) proposed rule on the Renewable Fuel Standard Program: Standards for 2019 and Biomass-Based Diesel Volume for 2020 (proposed rule).
Read More

BIO Submits Comments on FDA Draft Guidance: Limited Population Pathway for Antibacterial and Antifungal Drugs
Letters, Testimony & Comments  •  August 14, 2018
Re: Docket No. FDA-2018-D-2032: The Biotechnology Innovation Organization (BIO) is pleased to submit the following comments on the Food and Drug Administration (FDA) Draft Guidance, “Limited Population Pathway for Antibacterial and Antifungal Drugs (LPAD); Draft Guidance for Industry.” 
Read More

BIO Releases Statement on NGA’s Report on Prescription Drug Costs
Press Release  •  August 10, 2018
Washington, DC (August 10, 2018) – Tom Dilenge, president of advocacy, law & public policy at the Biotechnology Innovation Organization (BIO), issued the following statement today after the National Governors Association (NGA) released a report outlining “potential state strategies” to address prescription drug costs...
Read More

BIO Comments on FDA Draft Guidance on Considerations for the Inclusion of Adolescent Patients in Adult Oncology Clinical Trials
Letters, Testimony & Comments  •  August 3, 2018
BIO submitted comments on the Food and Drug Administration’s (FDA) Draft Guidance, Considerations for the Inclusion of Adolescent Patients in Adult Oncology Clinical Trials. The draft guidance is an important step towards ensuring stakeholders understand FDA’s expectations regarding the inclusion of adolescents in clinical trials for oncology products. BIO asks the FDA to consider reviewing and discussing the draft guidance with other global health authorities during pediatric cluster calls and asks for educational efforts directed towards institutional review boards (IRBs), which will be critical for successful implementation of the draft guidance. In addition, BIO asks for clarification on how the draft guidance relates to the Pediatrics Research Equity Act (PREA) and the FDA Reauthorization Act of 2017, Section 504, Development of Drugs and Biological Products for Pediatric Cancers. BIO requests case examples demonstrating circumstances in which adolescents have different physiology and/or psychology relative to adults. BIO’s comments include general suggestions as well as line edits.
Read More

BIO Led Coalition Letter in Support of Cellulosic Biofuel Technologies
Letters, Testimony & Comments  •  July 31, 2018
As the U.S. Environmental Protection Agency (EPA) begins its work to develop the proposed 2019 Renewable Fuel Standard (RFS) Renewable Volume Obligation (RVO), we encourage the agency to take a renewed look at commercial-ready cellulosic biofuels.
Read More

Congressman Tom Suozzi to Spotlight Scientific and Economic Development Advancements in New York
Press Release  •  July 27, 2018
Congressman Tom Suozzi will join leaders of New York’s biotechnology community for a tour of Alexandria LaunchLabs on Monday, July 30, 2018 at 11:00 am.
Read More

Letter to Rep. Barbara Comstock in Support of SUCCESS Act of 2018
Letters, Testimony & Comments  •  July 26, 2018
BIO sent the following letter to Representative Barbara Comstock following her introduction of H.R. 6390, the “Study of Underrepresented Classes Chasing Engineering and Science Success Act of 2018” or the SUCCESS Act  
Read More

BIO Wraps Up Transformative 2018 BIO World Congress in Philadelphia
Agriculture & Environment, BIO One-on-One Partnering  •  Press Release  •  July 19, 2018
Philadelphia (July 19, 2018) – The 15th annual BIO World Congress on Industrial Biotechnology concluded today at the Pennsylvania Convention Center in Philadelphia. The BIO World Congress continues to be the largest industrial biotechnology conference in the world, and this year’s event had a significant international presence with 44 percent of attendees coming from outside the United States. Additionally, more than 100 new companies were in attendance in Philadelphia.
Read More

BIO Announces Dr. Larry Walker as the Leadership and Legacy Award Recipient at the 2018 BIO World Congress
Press Release  •  July 19, 2018
Philadelphia (July 19, 2018) –The Biotechnology Innovation Organization (BIO) today presented Dr. Larry Walker, co-editor in chief for the journal “Industrial Biotechnology,” with the third annual BIO Leadership and Legacy Award in Industrial Biotechnology and Agriculture. The award presentation took place during a lunch plenary session at the 2018 BIO World Congress on Industrial Biotechnology. The world’s largest industrial biotechnology and partnering event was held July 16-19, 2018 at the Pennsylvania Convention Center in Philadelphia.
Read More